These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38841615)

  • 1. Digital biomarkers: 3PM approach revolutionizing chronic disease management - EPMA 2024 position.
    Smokovski I; Steinle N; Behnke A; Bhaskar SMM; Grech G; Richter K; Niklewski G; Birkenbihl C; Parini P; Andrews RJ; Bauchner H; Golubnitschaja O
    EPMA J; 2024 Jun; 15(2):149-162. PubMed ID: 38841615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.
    Golubnitschaja O; Polivka J; Potuznik P; Pesta M; Stetkarova I; Mazurakova A; Lackova L; Kubatka P; Kropp M; Thumann G; Erb C; Fröhlich H; Wang W; Baban B; Kapalla M; Shapira N; Richter K; Karabatsiakis A; Smokovski I; Schmeel LC; Gkika E; Paul F; Parini P; Polivka J
    EPMA J; 2024 Mar; 15(1):1-23. PubMed ID: 38463624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine.
    Bajinka O; Ouedraogo SY; Golubnitschaja O; Li N; Zhan X
    EPMA J; 2024 Jun; 15(2):289-319. PubMed ID: 38841622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions.
    Kucera R; Pecen L; Topolcan O; Dahal AR; Costigliola V; Giordano FA; Golubnitschaja O
    EPMA J; 2020 Sep; 11(3):399-418. PubMed ID: 32843909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caution, "normal" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021.
    Golubnitschaja O; Liskova A; Koklesova L; Samec M; Biringer K; Büsselberg D; Podbielska H; Kunin AA; Evsevyeva ME; Shapira N; Paul F; Erb C; Dietrich DE; Felbel D; Karabatsiakis A; Bubnov R; Polivka J; Polivka J; Birkenbihl C; Fröhlich H; Hofmann-Apitius M; Kubatka P
    EPMA J; 2021 Sep; 12(3):243-264. PubMed ID: 34422142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All around suboptimal health - a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine.
    Wang W; Yan Y; Guo Z; Hou H; Garcia M; Tan X; Anto EO; Mahara G; Zheng Y; Li B; Kang T; Zhong Z; Wang Y; Guo X; Golubnitschaja O;
    EPMA J; 2021 Dec; 12(4):403-433. PubMed ID: 34539937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine.
    Zhan X; Li J; Guo Y; Golubnitschaja O
    EPMA J; 2021 Dec; 12(4):449-475. PubMed ID: 34876936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach.
    Golubnitschaja O; Potuznik P; Polivka J; Pesta M; Kaverina O; Pieper CC; Kropp M; Thumann G; Erb C; Karabatsiakis A; Stetkarova I; Polivka J; Costigliola V
    EPMA J; 2022 Dec; 13(4):535-545. PubMed ID: 36415625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive, preventive and personalised approach as a conceptual and technological innovation in primary and secondary care of inflammatory bowel disease benefiting affected individuals and populations.
    Arosa L; Camba-Gómez M; Golubnitschaja O; Conde-Aranda J
    EPMA J; 2024 Mar; 15(1):111-123. PubMed ID: 38463620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context.
    Skladany L; Koller T; Adamcova Selcanova S; Vnencakova J; Jancekova D; Durajova V; Laffers L; Svac J; Janickova K; Palkovič M; Kohout P; Golubnitschaja O
    EPMA J; 2021 Mar; 12(1):1-14. PubMed ID: 33680218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revolutionizing Sleep Health: The Emergence and Impact of Personalized Sleep Medicine.
    Garbarino S; Bragazzi NL
    J Pers Med; 2024 Jun; 14(6):. PubMed ID: 38929819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management.
    Liskova A; Samec M; Koklesova L; Giordano FA; Kubatka P; Golubnitschaja O
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32854390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects-the evidence-based 3PM proposition to mitigate individual risks.
    Liskova A; Koklesova L; Samec M; Abdellatif B; Zhai K; Siddiqui M; Šudomová M; Hassan STS; Kudela E; Biringer K; Giordano FA; Büsselberg D; Golubnitschaja O; Kubatka P
    EPMA J; 2021 Sep; 12(3):325-347. PubMed ID: 34367380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care-clinically relevant 3PM innovation.
    Golubnitschaja O; Kapinova A; Sargheini N; Bojkova B; Kapalla M; Heinrich L; Gkika E; Kubatka P
    EPMA J; 2024 Jun; 15(2):163-205. PubMed ID: 38841620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-faceted CRISPR/Cas technological innovation aspects in the framework of 3P medicine.
    Lučanský V; Holubeková V; Kolková Z; Halašová E; Samec M; Golubnitschaja O
    EPMA J; 2023 Jun; 14(2):201-217. PubMed ID: 37275547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Emergency Medical Team Operating System - a vision for field hospital data management in following the concepts of predictive, preventive, and personalized medicine.
    Gaebel J; Schreiber E; Neumuth T
    EPMA J; 2024 Jun; 15(2):405-413. PubMed ID: 38841618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 what have we learned? The rise of social machines and connected devices in pandemic management following the concepts of predictive, preventive and personalized medicine.
    Radanliev P; De Roure D; Walton R; Van Kleek M; Montalvo RM; Santos O; Maddox L; Cannady S
    EPMA J; 2020 Sep; 11(3):311-332. PubMed ID: 32839666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobile 5P-Medicine Approach for Cardiovascular Patients.
    Pires IM; Denysyuk HV; Villasana MV; Sá J; Lameski P; Chorbev I; Zdravevski E; Trajkovik V; Morgado JF; Garcia NM
    Sensors (Basel); 2021 Oct; 21(21):. PubMed ID: 34770292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediterranean diet in the targeted prevention and personalized treatment of chronic diseases: evidence, potential mechanisms, and prospects.
    Xiao Y; Xiao X; Zhang X; Yi D; Li T; Hao Q; Zhang F; Li X; Wang N
    EPMA J; 2024 Jun; 15(2):207-220. PubMed ID: 38841625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.